T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Cellecta, Inc., Mountain View, CA.

Nanomedicine. 2013;8(7):1173-1189.

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

Tolerogenic dendritic cells in the intestines are shown to reduce the immune responses caused by exposure to food proteins.

New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

One of the very important factors contributing to ICI resistance is the dysfunction of antigen-presenting cells (APCs), especially dendritic cells (DCs), which are key initiators of the anti-tumor ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...